Varex CFO exercises 160,944 options, sells 130,000

Varex Imaging’s CFO exercised 160,944 options and sold 130,000 shares in a broker-assisted sell-to-cover transaction, retaining the remaining exercised shares.

Rhea-AI Filing Summary

Varex Imaging Corp (VREX) reported that Chief Financial Officer Shubham Maheshwari exercised 160,944 stock options on September 11, 2026 at an exercise price of $13.61 per share, receiving the same number of common shares. On the same day, 130,000 shares were sold at a weighted average price of $18.462 in a broker-assisted sell-to-cover transaction used solely to pay the option exercise price, related tax withholdings and broker fees, with all remaining shares from the exercise retained. The reported holdings include 2,137 shares acquired through the company’s 2017 Employee Stock Purchase Plan since the prior ownership report, and the options exercised were from a performance grant that finished vesting over four years ending in August 2025.

Insider Trade Summary

Exercise and sale activity reported; no spread calculated

Exercise and Sale 3 txns

Insider Maheshwari Shubham

Role Chief Financial Officer

Sold 130,000 shs ($2.40M)

Approx. gross sale proceeds $2.40M

Approx. exercise cost $2.19M

Type	Security	Shares	Price	Value
Exercise	Non-Qualified Stock Option (right to buy) F4	160,944	$0.00	$0.00
Exercise	Common Stock F1	160,944	$13.61	$2.19M
Sale	Common Stock F2, F3	130,000	$18.462	$2.40M

Holdings After Transaction: Non-Qualified Stock Option (right to buy) — 0 contracts (Direct); Common Stock — 139,972 shares (Direct)

Footnotes (4)

1. F1. Includes 2,137 shares purchased under the Varex Imaging Corporation 2017 Employee Stock Purchase Plan since the last Form 4 filing of the reporting person.
2. F2. The sales reported on this Form 4 were effected pursuant to a broker-assisted sell-to-cover exercise of fully vested options. The shares were sold solely to cover the aggregate exercise price, applicable tax withholdings and broker's fees. The reporting person retained all remaining shares acquired upon exercise.
3. F3. The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $18.460 to $18.470. The reporting person undertakes to provide Varex Imaging Corporation, any security holder of Varex Imaging Corporation or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
4. F4. These Performance Stock Options were subject to a four-year vesting schedule. 25% of the total number of options vested on August 15, 2021 and the remaining options vested monthly thereafter on a pro rata basis.

Key Figures

Options exercised: 160,944 shares Option exercise price: $13.61 per share Shares sold: 130,000 shares +4 more

7 metrics

Options exercised 160,944 shares Stock options exercised by the CFO on September 11, 2026

Option exercise price $13.61 per share Exercise price for 160,944 performance stock options

Shares sold 130,000 shares Common shares sold in a broker-assisted sell-to-cover transaction on September 11, 2026

Weighted average sale price $18.462 per share Weighted average price for 130,000 shares sold; individual prices ranged from $18.460 to $18.470

Option expiration date August 15, 2030 Expiration date of the performance stock options that were exercised

ESPP shares included 2,137 shares Shares purchased under the 2017 Employee Stock Purchase Plan since the prior Form 4

Vesting schedule 4 years Performance stock options vested 25% on August 15, 2021 with remaining options vesting monthly thereafter

Key Terms

broker-assisted sell-to-cover, weighted average price, Performance Stock Options, Employee Stock Purchase Plan

4 terms

broker-assisted sell-to-cover financial

"The sales reported on this Form 4 were effected pursuant to a broker-assisted sell-to-cover exercise of fully vested options."

weighted average price financial

"The price reported in column 4 is a weighted average price."

Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.

Performance Stock Options financial

"These Performance Stock Options were subject to a four-year vesting schedule."

Employee Stock Purchase Plan financial

"Includes 2,137 shares purchased under the Varex Imaging Corporation 2017 Employee Stock Purchase Plan since the last Form 4 filing of the reporting person."

An employee stock purchase plan is a company program that lets workers buy shares through small payroll deductions, often at a discount to the market price and after a set offering period. Think of it like a workplace savings plan that turns into ownership: it encourages employees to share in the company’s success and can create predictable buying or selling of stock that investors watch because it affects supply, demand and employee incentives.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transactions did VREX’s CFO report on September 11, 2026?

The CFO of VREX exercised 160,944 stock options at $13.61 per share, received the same number of common shares, and sold 130,000 shares in a broker-assisted sell-to-cover transaction at a weighted average price of $18.462 per share.

How many VREX shares did the CFO sell and at what price?

The CFO sold 130,000 shares of VREX common stock at a weighted average price of $18.462 per share, with individual sale prices ranging from $18.460 to $18.470, on September 11, 2026.

Were the VREX insider share sales part of a sell-to-cover transaction?

Yes. The filing states the sales were broker-assisted sell-to-cover transactions made solely to pay the aggregate option exercise price, applicable tax withholdings and broker’s fees, and that the reporting person retained all remaining shares acquired upon exercise.

What option grant did the VREX CFO exercise in this Form 4?

The CFO exercised performance stock options for 160,944 shares with an exercise price of $13.61 per share. These options vested over four years, with 25% vesting on August 15, 2021 and the remainder vesting monthly thereafter, and were scheduled to expire on August 15, 2030.

Does the Form 4 mention additional VREX shares purchased through an employee plan?

Yes. The reported holding figure includes 2,137 shares purchased under the Varex Imaging Corporation 2017 Employee Stock Purchase Plan since the CFO’s last Form 4 filing.

Were the VREX insider transactions made under a Rule 10b5-1 trading plan?

No Rule 10b5-1 trading plan is indicated. The filing’s plan-related checkbox is not marked as being made under such a plan, and the footnotes describe the sales as broker-assisted sell-to-cover transactions.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 09/15/2026 - 05:45 PM Accepted by SEC EDGAR 09/15/2026 - 05:44 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Maheshwari Shubham

(Last) (First) (Middle)

1678 S. PIONEER ROAD

(Street)

SALT LAKE CITY UTAH 84104

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Varex Imaging Corp [ VREX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Financial Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
09/11/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	09/11/2026		M		160,944	A	$13.61	269,972(1)	D
Common Stock	09/11/2026		S		130,000(2)	D	$18.462(3)	139,972	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Non-Qualified Stock Option (right to buy)	$13.61	09/11/2026		M			160,944	(4)	08/15/2030	Common Stock	160,944	$0	0	D

Explanation of Responses:

1. Includes 2,137 shares purchased under the Varex Imaging Corporation 2017 Employee Stock Purchase Plan since the last Form 4 filing of the reporting person.

2. The sales reported on this Form 4 were effected pursuant to a broker-assisted sell-to-cover exercise of fully vested options. The shares were sold solely to cover the aggregate exercise price, applicable tax withholdings and broker's fees. The reporting person retained all remaining shares acquired upon exercise.

3. The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $18.460 to $18.470. The reporting person undertakes to provide Varex Imaging Corporation, any security holder of Varex Imaging Corporation or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

4. These Performance Stock Options were subject to a four-year vesting schedule. 25% of the total number of options vested on August 15, 2021 and the remaining options vested monthly thereafter on a pro rata basis.

Remarks:

	/s/ Shubham Maheshwari	09/15/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)